Americans Spent $30 Billion Out of Pocket on Complementary Health Approaches
Carfilzomib Plus Dexamethasone Approved by EC for Multiple Myeloma
Another One Bites the Dust: Risk Adjustment Program Claims Connecticut's Co-op
FDA Panel Narrowly OKs Empagliflozin CV Benefit Claim
Healthcare Lawsuits: UnitedHealth Alleges Fraud and Anthem, Express Scripts Accused of Overcharging
BRCA1 Mutations Can Lead to Lethal Uterine Cancer
What We're Reading: Obamacare Exchange Close to Collapse in South Carolina
Formal Dementia Diagnosis Reduces Risk of Performing Unsafe Activities
Health IT Essential for the Success of Cancer Moonshot
Despite Lower Prices, Cancer Drugs Less Affordable in Lower-Income Countries
Blue Cross of Georgia Sued for Sending Checks to Patients, Not Hospitals
Safety Profile of New Pan-Genomic HCV Drug Similar to Current Treatments
Support for Physician-Assisted Death High Across Ethnicities
This Week in Managed Care: July 2, 2016
Patients With Diabetes Spend $10K More a Year Than Patients Without Diabetes
AJMC in the Press, July 1, 2016
What We're Reading: DOJ Skeptical About Anthem-Cigna Merger
Achieving Data-Driven Success Under the Oncology Care Model
What We're Reading: A New Approach to Care for Super-Utilizers
5 Facts About Urgent Care Clinics
Too Much or Too Little Sleep May Raise Diabetes Risk in Men
Mandate Will Ensure Researchers, Companies Report Clinical Trial Data, Says Collins
What We're Reading: Should the FDA Change How Drugs Are Approved in the US?
Necessity Breeds Innovation in Louisiana's Novel Medicaid Expansion
Aspirin Instead of Blood Thinners Often Prescribed for Patients With Atrial Fibrillation
Claiming "Orphan" Status, AstraZeneca Sues FDA to Protect Crestor Patent
CMS Announces Practices and Payers Participating in the OCM
HHS Names Physical Activity Guidelines Panel
World Economic Forum Group Honors Omada Health for Medical Innovation
Pharmaceutical Pricing: Competition and Market Demands